About

Science

Information

Home

Event Calendar
Show only selected Events
Date to
Reset | Calendar

Friday, March 01, 2019

9:00am - 10:00am
Simches 3120
Other Lectures
Evolutionary mathematical modeling enables optimization of glioblastoma treatment strategies
Franziska Michor, Ph.D.

Neuro-Oncology Research Seminar Series

Wednesday, May 08, 2019

8:00am - 9:00am
MGH - Haber Auditorium
Other Lectures
T32 Lecture Series
Mikael Pittet, PhD

Samana Cay MGH Research Scholar 2015-2020; Investigator, Center for Systems Biology; Associate Professor of Radiology, Harvard Medical School

Friday, May 17, 2019

7:30am - 4:50pm
The Joseph B. Martin Conference Center @ Harvard Medical School, 77 Avenue Louis Pasteur, Boston MA
Other Lectures
Advances in Cancer Immunotherapy: Annual Update
TBD

http://image.email.externaled.hms.harvard.edu/lib/fe9813737566017d73/m/1/8784ebdb-2d25-46c4-b361-655a2f08fe2e.jpg
Advances in Cancer Immunotherapy:
Annual Update

Friday, May 17, 2019 - Saturday, May 18, 2019
The Joseph B. Martin Conference Center
Boston, MA

Dear Colleague,

Cancer treatment has evolved significantly over the past decade from a treatment paradigm anchored on surgery, chemotherapy, and radiotherapy, to one embracing molecularly-targeted therapies disrupting tumor-specific signaling pathways, as well as new approaches to mobilize the immune system. The pace of these developments has brought new challenges for physicians in clinical practice, trying to keep pace with advancing immuno-oncology principles and research. Recognizing these challenges, this course will provide a comprehensive clinical review of the advances taking place in the immuno-oncology field. It is suited to those practicing oncologists and professionals interested in learning more about immune-oncology approaches and the challenges of managing patients with new agents. The course is designed to enhance learners’ competence and performance in practice and will engage learners through interactive Q&A sessions with the faculty, along with didactic presentations.

For more information, visit the Advances in Cancer Immunotherapy: Annual Update website.

Sincerely,
Mark Cobbold, MD, PhD
Justin Gainor, MD
Krista Rubin, MS, FNP-BC

The Harvard Medical School designates this live activity for a maximum of 11.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

https://cmeregistration.hms.harvard.edu/events/advances-in-cancer-immunotherapy-annual-update/event-summary-ade9a65132da4693928568e095360413.aspx

Saturday, May 18, 2019

7:30am - 12:00pm
The Joseph B. Martin Conference Center @ Harvard Medical School, 77 Avenue Louis Pasteur, Boston MA
Other Lectures
Advances in Cancer Immunotherapy: Annual Update
TBD

http://image.email.externaled.hms.harvard.edu/lib/fe9813737566017d73/m/1/8784ebdb-2d25-46c4-b361-655a2f08fe2e.jpg
Advances in Cancer Immunotherapy:
Annual Update

Friday, May 17, 2019 - Saturday, May 18, 2019
The Joseph B. Martin Conference Center
Boston, MA

Dear Colleague,

Cancer treatment has evolved significantly over the past decade from a treatment paradigm anchored on surgery, chemotherapy, and radiotherapy, to one embracing molecularly-targeted therapies disrupting tumor-specific signaling pathways, as well as new approaches to mobilize the immune system. The pace of these developments has brought new challenges for physicians in clinical practice, trying to keep pace with advancing immuno-oncology principles and research. Recognizing these challenges, this course will provide a comprehensive clinical review of the advances taking place in the immuno-oncology field. It is suited to those practicing oncologists and professionals interested in learning more about immune-oncology approaches and the challenges of managing patients with new agents. The course is designed to enhance learners’ competence and performance in practice and will engage learners through interactive Q&A sessions with the faculty, along with didactic presentations.

For more information, visit the Advances in Cancer Immunotherapy: Annual Update website.

Sincerely,
Mark Cobbold, MD, PhD
Justin Gainor, MD
Krista Rubin, MS, FNP-BC

The Harvard Medical School designates this live activity for a maximum of 11.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

https://cmeregistration.hms.harvard.edu/events/advances-in-cancer-immunotherapy-annual-update/event-summary-ade9a65132da4693928568e095360413.aspx

Wednesday, August 28, 2019

8:00am - 9:00am
MGH - Haber Auditorium
Other Lectures
T32 Lecture Series
Mario Suvà, MD, PhD

Assistant Professor of Pathology and Assistant Molecular Pathologist, MGH; Associated Scientist Broad Institute of MIT and Harvard

Wednesday, November 06, 2019

8:00am - 9:00am
MGH - Haber Auditorium
Other Lectures
T32 Lecture Series
Matt Vander Heiden, MD, PhD

Associate Professor of Biology, Associate Director, Koch Institute for Integrative Cancer Research